InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: None

Wednesday, 07/12/2017 4:48:09 PM

Wednesday, July 12, 2017 4:48:09 PM

Post# of 16911
And no trials planned for probuphine for chronic pain...

...because no competing implants are in development. They are racing against Indivior, and spending all the R&D money to be able to compete with them.

Why not exploit the market (buprenorphine implant) with no competition?

https://www.biospace.com/News/camurus-and-braeburn-pharma-announce-topline-phase/462724/source=MoreNews
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News